3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
9
Breast Neoplasms
7
Neoplasms
4
Lymphoma
4
Brain Neoplasms
4
Lymphoma, Non-Hodgkin
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Leukemia
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma in Situ
2
Burkitt Lymphoma
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Vasculitis
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Osteomyelitis
1
Neurofibromatosis 1
1
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
62
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
23
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
Nivolumab
11
rucaparib
10
durvalumab
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
Magnetic Resonance Imaging
×
Clear all
No trials found.